Acadia Healthcare (NASDAQ:ACHC) has been given a $42.00 target price by equities research analysts at Jefferies Group in a research report issued to clients and investors on Tuesday. The firm presently has a “buy” rating on the stock. Jefferies Group’s price target would indicate a potential upside of 29.15% from the stock’s previous close.
ACHC has been the topic of several other reports. BMO Capital Markets initiated coverage on shares of Acadia Healthcare in a research report on Monday, October 16th. They set an “outperform” rating and a $52.00 target price on the stock. KeyCorp restated a “buy” rating and set a $59.00 target price on shares of Acadia Healthcare in a research report on Friday, October 20th. Mizuho set a $60.00 target price on shares of Acadia Healthcare and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, October 12th. Finally, Citigroup decreased their target price on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating on the stock in a research report on Wednesday, October 25th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company. Acadia Healthcare presently has a consensus rating of “Hold” and an average target price of $45.08.
Acadia Healthcare (NASDAQ ACHC) traded up $0.66 during trading hours on Tuesday, reaching $32.52. 1,520,600 shares of the company were exchanged, compared to its average volume of 1,345,410. Acadia Healthcare has a 1 year low of $26.92 and a 1 year high of $54.34. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. The stock has a market cap of $2,788.47, a price-to-earnings ratio of 13.86, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90.
In other news, Director Reeve B. Waud sold 100,000 shares of Acadia Healthcare stock in a transaction on Friday, December 15th. The stock was sold at an average price of $31.80, for a total transaction of $3,180,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.
Several large investors have recently added to or reduced their stakes in ACHC. Schwab Charles Investment Management Inc. raised its stake in shares of Acadia Healthcare by 13.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 330,515 shares of the company’s stock worth $16,321,000 after buying an additional 40,119 shares during the last quarter. Arizona State Retirement System acquired a new position in Acadia Healthcare in the 2nd quarter valued at about $1,591,000. First Trust Advisors LP raised its stake in Acadia Healthcare by 146.0% in the 2nd quarter. First Trust Advisors LP now owns 299,519 shares of the company’s stock valued at $14,790,000 after purchasing an additional 177,756 shares during the last quarter. Teacher Retirement System of Texas raised its stake in Acadia Healthcare by 0.4% in the 2nd quarter. Teacher Retirement System of Texas now owns 5,949 shares of the company’s stock valued at $294,000 after purchasing an additional 26 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Acadia Healthcare by 72.0% in the 2nd quarter. Rhumbline Advisers now owns 141,100 shares of the company’s stock valued at $6,968,000 after purchasing an additional 59,077 shares during the last quarter.
ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking and Market News and is the property of of American Banking and Market News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2017/12/19/acadia-healthcare-achc-pt-set-at-42-00-by-jefferies-group.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
